A pharma manufacturer set the specification limits for the API content uniformity of its tablets as 170 mg to 230 mg (+/-15% of the target value of 200 mg). A random sample of 30 tablets from a production batch was analyzed with the results of X-bar = 191 mg and S=8 mg. Is this a manufacturing process capable of consistently meeting that content uniformity specification? Calculate both capability indices described in the lecture. Discuss what can be done to improve that process's capability.